Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001806662 | SCV002050655 | pathogenic | not provided | 2023-04-21 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33879512) |
Prevention |
RCV003394262 | SCV004121090 | likely pathogenic | LHFPL5-related disorder | 2023-08-03 | criteria provided, single submitter | clinical testing | The LHFPL5 c.395G>A variant is predicted to result in premature protein termination (p.Trp132*). This variant has been reported in the homozygous state in a patient with profound bilateral sensorineural hearing loss, although this patient was also reported to have features not typically associated with this disorder of optic nerve hypoplasia, dystonia and dysmyelinating leukodystrophy (Supplementary Data 3, Molina-Ramírez. 2022. PubMed ID: 33879512). This variant is reported in 0.0031% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-35773842-G-A). Nonsense variants in LHFPL5 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |